- Home
- News
- latamerica
- physiological development
Physiological Development Articles & Analysis
8 news found
Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of 3D bioprinted tumor models based on cancer cell lines that improve accuracy and rapidly speed up drug development processes, driving down development costs and enabling an improved output. ...
ByCELLINK
Of Cypriot descent, Dr Christofides started his career in 1973 at Hammersmith Hospital, London, as a research assistant where he developed immunoassay for Oestriol and provided routine biochemistry services to the Obstetrics and Gynaecology department. This was quickly followed by a move to Endocrinology for 9 years as a senior research officer where numerous immunoassays were ...
In February 2019, Empatica and BARDA's Division of Research, Innovation and Ventures (DRIVe) began to develop a digital biomarker that predicts respiratory infections. Preliminary findings have been promising, showing a strong correlation between viral shedding and changes in a person's physiology. ...
In February 2019, Empatica and BARDA's Division of Research, Innovation and Ventures (DRIVe) began to develop a digital biomarker that predicts respiratory infections. Preliminary findings have been promising, showing a strong correlation between viral shedding and changes in a person's physiology. ...
He will be based in Boston and will be responsible for the Company’s hardware and software development, as well as data science capability. David’s appointment ensures that the Company is prepared to meet its ambitious growth plans and continued innovation. ...
About Poietis : Poietis is a biotechnology company specialized in the development and the manufacturing of human tissues using 4D bioprinting. Since its inception in 2014, the company has been developing different physiological models, particularly in partnership with the world’s leading pharmaceutical and cosmetic groups. ...
ByPoietis
“This long-term partnership to develop liver tissue with bioprinting technology is an important step in the deployment of 4D bioprinting in the pharmaceutical industry. ...
ByPoietis
“This is the right timing for us to enter into such a collaboration with a worldwide renowned Center in Tissue Development and Engineering as the Division led by Professor Luyten. The economical perspectives are tremendous for setting up a tissue manufacturing platform based on bioprinting and allowing the production of engineered implants/tissues for therapeutic ...
ByPoietis
